Time-course expression of metallothioneins and tissue metals in chronic relapsing form of experimental autoimmune encephalomyelitis

Histology and Histopathology

Volumn 26, Issue 2, 2011, Pages 233-245

  Jakovac, Hrvoje ^a   Grebić, Damir ^a   Tota, Marin ^a   Barac Latas, Vesna ^a   Mrakovčić Šutić, Ines ^a   Milin, Čedomila ^a   Radoševic Stašic, Biserka ^a  

^a UNIVERSITY OF RIJEKA   (Croatia)

Author keywords

Chronic relapsing experimental autoimmune encephalomyelitis; CNS; Copper; Liver; Metallothioneins I+II; Zinc

Indexed keywords

COPPER; METALLOTHIONEIN; ZINC;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; CATTLE; CENTRAL NERVOUS SYSTEM; CHEMISTRY; CHRONIC DISEASE; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; LIVER; METABOLISM; PATHOLOGY; RAT; RAT STRAIN; RECURRENT DISEASE; TIME;

ANIMALS; CATTLE; CENTRAL NERVOUS SYSTEM; CHRONIC DISEASE; COPPER; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; IMMUNOHISTOCHEMISTRY; LIVER; METALLOTHIONEIN; RATS; RATS, INBRED STRAINS; RECURRENCE; SPECTROPHOTOMETRY, ATOMIC; TIME FACTORS; ZINC;

AGOUTI; BOVINAE; RATTUS;

EID: 78651299939     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Ambjřrn M., Asmussen J. W., Lindstam M., Gotfryd K., Jacobsen C., Kiselyov V. V., Moestrup S. K., Penkowa M., Bock E. and Berezin V. (2008). Metallothionein and a peptide modeled after metallothionein, EmtinB, induce neuronal differentiation and survival through binding to receptors of the low-density lipoprotein receptor family. J. Neurochem. 104, 21-37.
2. Aschner M. (1996). The functional significance of brain metallothioneins. FASEB J. 10, 1129-1136.
3. + release. Brain Res. 813, 254-261.
4. Asmussen J. W., Von Sperling M. L. and Penkowa M. (2009). Intraneuronal signaling pathways of metallothionein. J. Neurosci. Res. 87, 2926-2936.
5. Ballabh P., Braun A. and Nedergaard M. (2004). The blood-brain barrier, an overview, Structure, regulation, and clinical implications. Neurobiol. Dis. 16, 1-13.
6. Becher B., Bechmann I. and Greter M. (2006). Antigen presentation in autoimmunity and CNS inflammation, how T lymphocytes recognize the brain. J. Mol. Med. 84, 532-543.
7. Bendelac A., Savage P. B. and Teyton L. (2007). The Biology of NKT Cells doi, 10.1146/annurev. immunol.25.022106.141711. Annu. Rev. Immunol. 25, 297-336.
8. Centonze D., Muzio L., Rossi S., Cavasinni F., De Chiara V., Bergami A., Musella A., D'Amelio M., Cavallucci V., Martorana A., Bergamaschi A., Cencioni M. T., Diamantini A., Butti E., Comi G., Bernardi G., Cecconi F., Battistini L., Furlan R. and Martino G. (2009). Inflammation triggers synaptic alteration and degeneration in experimental autoimmune encephalomyelitis. J. Neurosci. 29, 3442-3452.
9. Cherian M. G. and Kang Y. J. (2006). Metallothionein and Liver Cell Regeneration. Exp. Biol. Med. 231, 138-144.
10. Chung R. S., Hidalgo J. and West A. K. (2008). New insight into the molecular pathways of metallothionein-mediated neuroprotection and regeneration. J. Neurochem. 104, 14-20.
11. Coyle P., Philcox J. C., Carey L. C. and Rofe A. M. (2002). Metallothionein, the multipurpose protein. Cell. Mol. Life Sci. 59, 627-647.
12. Crispe I. N. (2009). The liver as a lymphoid organ. Annu. Rev. Immunol. 27, 147-163.
13. Ebadi M., Iversen P. L., Hao R., Cerutis D. R., Rojas P., Happe H. K., Murrin L. C. and Pfeiffer R. F. (1995). Expression and regulation of brain metallothionein. Neurochem. Int. 27, 1-22.
14. Engelhardt B. and Sorokin L. (2009). The blood-brain and the bloodcerebrospinal fluid barriers, function and dysfunction. Semin. Immunopathol. 31, 497-511.
15. Espejo C., Penkowa M., Demestre M., Montalban X. and Martínez- Cáceres E. M. (2005). Time-course expression of CNS inflammatory, neurodegenerative tissue repair markers and metallothioneins during experimental autoimmune encephalomyelitis. Neuroscience 132, 1135-1149.
16. Gabbi C., Warner M. and Gustafsson J.-A. (2009). Minireview, Liver X Receptor {beta}, Emerging Roles in Physiology and Diseases. 10.1210/me.2008- 0398. Mol Endocrinol. 23, 129-136.
17. Giralt M., Penkowa M., Lago N., Molinero A. and Hidalgo J. (2002). Metallothionein-1+2 protect the CNS after a focal brain injury. Exp. Neurol. 173, 114-128.
18. Grebic D., Jakovac H., Mrakovcic-Sutic I., Tomac J., Bulog A., Micovic V. and Radosevic-Stasic B. (2007). Short-term exposure of mice to gasoline vapor increases the metallothionein expression in the brain, lungs and kidney. Histol. Histopathol. 22, 593-601.
19. Haq F., Mahoney M. and Koropatnick J. (2003). Signaling events for metallothionein induction. Mutat. Res. 533, 211-226.
20. Hidalgo J., Aschner M., Zatta P. and Vasák M. (2001). Roles of the metallothionein family of proteins in the central nervous system. Brain Res. Bull. 55, 133-145.
21. Hidalgo J., Giralt M., Garvey J. S. and Armario A. (1988). Physiological role of glucocorticoids on rat serum and liver metallothionein in basal and stress conditions. Am. J. Physiol. 254, E71-78.
22. Jakovac H., Grebic D., Mrakovcic-Sutic I., Tota M., Broznic D., Marinic J., Tomac J., Milin C. and Radosevic-Stasic B. (2006). Metallothionein expression and tissue metal kinetics after partial hepatectomy in mice. Biol. Trace Elem. Res. 114, 249-268.
23. Kozlowski H., Janicka-Klos A., Brasun J., Gaggelli E., Valensin D. and Valensin G. (2009). Copper, iron, and zinc ions homeostasis and their role in neurodegenerative disorders (metal uptake, transport, distribution and regulation). Coord. Chem. Rev. 253, 2665-2685.
24. Lichtlen P. and Schaffner W. (2001). The "metal transcription factor" MTF-1, biological facts and medical implications. Swiss Med. Wkly. 131, 647-652.
25. Maret W. (2006). Zinc coordination environments in proteins as redox sensors and signal transducers. Antioxid. Redox Sign. 8, 1419-1441.
26. Mocchegiani E. and Malavolta M. (2004). NK and NKT cell functions in immunosenescence. Aging Cell 3, 177-184.
27. Mocchegiani E., Giacconi R., Muzzioli M. and Cipriano C. (2002). Altered zinc binding by metallothioneins in immune-neuroendocrine senescence, a vicious circle between metallothioneins and chaperones?. Advances in cell aging and gerontology. In: Basic biology and clinical impact of immunosenescence. Pawelec G. (ed). Elsevier. pp 261-281.
28. Mocchegiani E., Giacconi R., Muti E., Rogo C., Bracci M., Muzzioli M., Cipriano C. and Malavolta M. (2004). Zinc, immune plasticity, aging, and successful aging, role of metallothionein. Ann. NY Acad. Sci. 1019, 127-134.
29. Mocchegiani E., Bertoni-Freddari C., Marcellini F. and Malavolta M. (2005). Brain, aging and neurodegeneration. Role of zinc ion availability. Prog. Neurobiol. 75, 367-390.
30. Mocchegiani E., Giacconi R., Cipriano C. and Malavolta M. (2009). NK and NKT cells in aging and longevity, role of zinc and metallothioneins. J. Clin. Immunol. 29, 416-425.
31. Moffatt P. and Denizeau F. (1997). Metallothionein in physiological and physiopathological processes. Drug. Metab. Rev. 29, 261-307.
32. Pedersen M.Ø., Jensen R., Pedersen D. S., Skjolding A. D., Hempel C., Maretty L. and Penkowa M. (2009a). Metallothionein-I+II in neuroprotection. Biofactors 35, 315-325.
33. Pedersen M.Ø., Larsen A., Stoltenberg M. and Penkowa M. (2009b). The role of metallothionein in oncogenesis and cancer prognosis. Progr. Histochem. Cytochem. 44, 29-64.
34. Penkowa M. and Hidalgo J. (2000). Metallothionein I+II expression and their role in experimental autoimmune encephalomyelitis. Glia 32, 247-263.
35. Penkowa M. and Hidalgo J. (2001). Metallothionein treatment reduces proinflammatory cytokines IL-6 and TNF-alpha and apoptotic cell death during experimental autoimmune encephalomyelitis (EAE). Exp. Neurol. 170, 1-14.
36. Penkowa M. and Hidalgo J. (2003). Treatment with metallothionein prevents demyelination and axonal damage and increases oligodendrocyte precursors and tissue repair during experimental autoimmune encephalomyelitis. J. Neurosci. Res. 72, 574-586.
37. Penkowa M., Hidalgo J. and Moos T. (1997). Increased astrocytic expression of metallothioneins I + II in brainstem of adult rats treated with 6-aminonicotinamide. Brain Res. 774, 256-259.
38. Penkowa M., Espejo C., Martinez-Caceres E. M., Montalban X. and Hidalgo J. (2003a). Increased demyelination and axonal damage in metallothionein I+II-deficient mice during experimental autoimmune encephalomyelitis. Cell. Mol. Life Sci. 60, 185-197.
39. Penkowa M., Espejo C., Ortega-Aznar A., Hidalgo J., Montalban X. and Martinez Caceres E. M. (2003b). Metallothionein expression in the central nervous system of multiple sclerosis patients. Cell. Mol. Life Sci. 60, 1258-1266.
40. Penkowa M., Caceres M., Borup R., Nielsen F. C., Poulsen C. B., Quintana A., Molinero A., Carrasco J., Florit S., Giralt M. and Hidalgo J. (2006). Novel roles for metallothionein-I + II (MT-I + II). in defense responses, neurogenesis, and tissue restoration after traumatic brain injury, insights from global gene expression profiling in wild-type and MT-I + II knockout mice. J. Neurosci. Res. 84, 1452-1474.
41. Prasad A. (2007). Zinc, mechanisms of host defense. J. Nutr. 137, 1345-1349.
42. Prohaska J. R. and Gybina A. A. (2004). Intracellular copper transport in mammals. J. Nutr. 134, 1003-1006.
43. Rink L. and Haase H. (2007). Zinc homeostasis and immunity. Trends Immunol. 28, 1-4.
44. Rothstein J. D., Dykes-Hoberg M., Corson L. B., Becker M., Cleveland D. W., Price D. L., Culotta V. C. and Wong P. C. (1999). The copper chaperone CCS is abundant in neurons and astrocytes in human and rodent brain. J. Neurochem. 72, 422-429.
45. Santodomingo-Garzon T., Han J., Le T., Yang Y. and Swain M. G. (2009). Natural killer T cells regulate the homing of chemokine CXC receptor 3-positive regulatory T cells to the liver in mice. Hepatology 49, 1267-1276.
46. Sato M. and Kondoh M. (2002). Recent studies on metallothionein, protection against toxicity of heavy metals and oxygen free radicals. Tohoku J. Exp. Med. 196, 9-22.
47. Sensi S. L., Paoletti P., Bush A. I. and Sekler I. (2009). Zinc in the physiology and pathology of the CNS. Nat. Rev. Neurosci. 10, 780-791.
48. Speak A. O. (2007). Implications for invariant natural killer T cell ligands due to the restricted presence of isoglobotrihexosylceramide in mammals. Proc. Natl. Acad. Sci. USA 104, 5971-5976.
49. Spitsin S., Portocarrero C., Phares T. W., Kean R. B., Brimer C. M., Koprowski H. and Hooper D. C. (2008). Early blood-brain barrier permeability in cerebella of PLSJL mice immunized with myelin basic protein. J. Neuroimmunol. 196, 8-15.
50. Swain M. G. (2008). Hepatic NKT cells, friend or foe? Clin. Sci. (Lond). 114, 457-466.
51. Thirumoorthy N., Kumar K. T. M., Sundar A. S., Panayappan L. and Chatterjee M. (2007). Metallothionein, an overview. World J. Gastroenterol. 13, 993-996.
52. Tonra J. R. (2002). Cerebellar susceptibility to experimental autoimmune encephalomyelitis in SJL/J mice, potential interaction of immunology with vascular anatomy. Cerebellum 1, 57-68.
53. West A. K., Hidalgo J., Eddins D., Levin E. D. and Aschner M. (2008). Metallothionein in the central nervous system, Roles in protection, regeneration and cognition. NeuroToxicol. 29, 489-503.
54. Wu L. and Van Kaer L. (2009). Natural killer T cells and autoimmune disease. Curr. Mol. Med. 9, 4-14.
55. Xu J., Wagoner G., Douglas J. C. and Drew P. D. (2009). Liver X receptor agonist regulation of Th17 lymphocyte function in autoimmunity. J. Leukoc. Biol. 86, 401-409.
56. Zajonc D. M., Maricic I., Wu D., Halder R., Roy K., Wong C.-H., Kumar V. and Wilson I. A. (2005). Structural basis for CD1d presentation of a sulfatide derived from myelin and its implications for autoimmunity. 10.1084/jem.20051625. J. Exp. Med. 202, 1517-1526.
57. Zeng J., Vallee B. L. and Kagi J. H. (1991). Zinc transfer from transcription factor IIIA fingers to thionein clusters. Proc. Natl. Acad. Sci. USA 88, 9984-9988.